Teva Pharmaceuticals Achieves Growth in Q3 2024 Despite Challenges
Daily NewsTeva Pharmaceuticals Industries Ltd. (NYSE: TEVA) performed well in the third quarter of 2024, with revenues increasing by 15% year-over-year to reach $4.3 billio...
Read More